Home › Therapeutic areas › Oncology › Sarcoma
Sarcoma (3 companies)
Companies with an active program in Sarcoma.
| Ticker | Company | Therapeutic areas | Programs | Lead stage | Mkt cap | Programs |
|---|---|---|---|---|---|---|
| ELTX | Elicio Therapeutics | Oncology | 1 | Phase 2 | $42.7M | 6 |
| MBRX | Moleculin Biotech | Oncology | 1 | Phase 2 | — | 8 |
| TLX | Telix Pharmaceuticals | Oncology | 2 | Approved | $3.27B | 25 |
No companies match.